CANDEL THERAPEUTICS INC. - COMMON STOCK
5.0400
22-November-24 16:44:58
15 minutes delayed
Stocks
+0.9050
+21.89%
Today's range
4.1900 - 5.5700
ISIN
N/A
Source
NASDAQ
-
Candel Therapeutics Receives FDA Fast Track Designation for CAN-2409 in Non-Small Cell Lung Cancer
17 Apr 2023 08:00:00 By Nasdaq GlobeNewswire
-
30 Mar 2023 08:00:01 By Nasdaq GlobeNewswire
-
Candel Therapeutics to Participate in Guggenheim Healthcare Talks 2023 Oncology Day
01 Feb 2023 08:00:01 By Nasdaq GlobeNewswire
-
Candel Therapeutics to Participate in Upcoming B. Riley Oncology Conference
12 Jan 2023 08:00:00 By Nasdaq GlobeNewswire
-
06 Dec 2022 16:26:35 By Nasdaq GlobeNewswire
-
Candel Therapeutics to Host Virtual R&D Day on December 6, 2022
29 Nov 2022 08:00:01 By Nasdaq GlobeNewswire
-
Candel Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
10 Nov 2022 08:00:03 By Nasdaq GlobeNewswire
-
Candel Therapeutics Announces Upcoming Clinical Data Presentations at SITC and SNO
07 Nov 2022 08:00:02 By Nasdaq GlobeNewswire
-
Candel Therapeutics Upcoming Investor Conference Participation for November
01 Nov 2022 08:00:03 By Nasdaq GlobeNewswire
-
15 Sep 2022 08:00:01 By Nasdaq GlobeNewswire
-
Candel Therapeutics Announces Two Executive Leadership Appointments
07 Sep 2022 08:00:02 By Nasdaq GlobeNewswire
-
Candel Therapeutics Upcoming Investor Conference Participation
06 Sep 2022 08:00:02 By Nasdaq GlobeNewswire
-
Candel Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights
05 Aug 2022 08:00:00 By Nasdaq GlobeNewswire
-
Candel Therapeutics to Present at the H.C. Wainwright Annual Global Investment Conference
18 May 2022 08:00:01 By Nasdaq GlobeNewswire
-
Candel Therapeutics Reports First Quarter 2022 Financial Results and Recent Corporate Highlights
12 May 2022 08:00:02 By Nasdaq GlobeNewswire
-
27 Apr 2022 16:00:00 By Nasdaq GlobeNewswire